Qualitative Factors Impacting Patients and Clinicians Regarding Intravitreal Injections for Retinal Disorders: A Scoping Review [PDF]
Clinical OphthalmologyAndrew Ly, Evan Harnick, Tanisha Jowsey, Amy Jean Bannatyne Faculty of Health Sciences & Medicine, Bond University, Gold Coast, QLD, AustraliaCorrespondence: Andrew Ly, Bond University 14 University Drive, Robina, Gold Coast, QLD, Australia, Tel +61 ...
Amy Bannatyne, Tanisha Jowsey
exaly +6 more sources
SAFETY OF INTRAVITREAL INJECTIONS [PDF]
Офтальмохирургия, 2017 Purpose. The aim of this study was to evaluate the method of intavitreal injections and its technique used for intravitreal injection procedure as well as possible intra- and post-injection complications and approaches used for their prevention. Material
I. E. Ioshin
doaj +3 more sources
Intravitreal Injection Technique [PDF]
MedEdPORTAL, 2016 Introduction Intravitreal injection of therapeutic medications has become one of the most commonly performed procedures in ophthalmology. Over the past decade, a number of guidelines have been published that recommend proper techniques to increase the ...
Kasra A. Rezaei, Joanne C. Wen
doaj +3 more sources
Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk [PDF]
International Journal of Retina and VitreousIntroduction Intravitreal injections are standard treatment for various manifestations of age-related macular degeneration (AMD) but are associated with rare complications, including central retinal vein occlusion (CRVO).
Michael Antonietti +3 more
doaj +2 more sources
Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes [PDF]
BMC OphthalmologyPurpose To investigate the incidence, contributing factors, management, and long-term outcomes of endophthalmitis following intravitreal injections performed in our clinic.
Sebile Comcali +10 more
doaj +2 more sources
Real-world incidence of endopthalmitis after intravitreal anti-VEGF injections in Korea: findings from the Common Data Model in ophthalmology [PDF]
Epidemiology and Health, 2021 OBJECTIVES The aim of this study was to evaluate the real-world incidence of endophthalmitis after intravitreal anti-vascular endothelial growth factor (VEGF) injections using data from the Observational Medical Outcomes Partnership (OMOP) Common Data ...
Yongseok Mun +15 more
doaj +1 more source
Clinical outcomes of intravitreal treatment for ocular toxoplasmosis: systematic review and meta-analysis [PDF]
Revista da Sociedade Brasileira de Medicina Tropical, 2023 Background: Ocular toxoplasmosis is the leading cause of infectious posterior uveitis worldwide, accounting for 30-50% of all cases in immunocompetent patients.
Lutiana Amaral de Melo +5 more
doaj +1 more source
Case Reports in Ophthalmology, 2021 Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is essential for the treatment of macular diseases such as wet age-related macular degeneration and macular edema.
Atsuta Ozaki +5 more
doaj +1 more source
The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
Ophthalmology Science, 2023 Purpose: To examine whether patients with diabetic retinopathy receiving intravitreal anti-VEGF injections are at increased risk of kidney function decline. Design: Retrospective cohort study. Participants: Included 187 patients who received intravitreal
Casey C. Bunge, MD +7 more
doaj +1 more source
Acute systemic complications of intravitreal bevacizumab and triamcinolone injections – a comparative study [PDF]
Folia Medica, 2022 Introduction: Macular edema is a common visual threatening complication in patients with diabetic retinopathy and retinal vein occlusion. The injection of intravitreal drugs, such as anti-vascular endothelial growth factor (anti-VEGF) and corticosteroids,
Mohammad Karim Johari +3 more
doaj +3 more sources